ShangPharma to Attend Upcoming Investor Conferences in September

SHANGHAI, Aug. 15, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its senior management will be participating in the following upcoming conferences in September 2011:

Mr. Michael Hui, founder and Chief Executive Officer of ShangPharma, and William Dai, Chief Financial Officer, will be presenting at the following conferences in New York City and Boston:

Ms. Lan Xie, Vice President of Finance and Investor Relations of ShangPharma, will be presenting at the following conference in London:

Presentation materials will be available under the Presentation section of the Company's investor relations website at http://ir.shangpharma.com.

About ShangPharma Corporation  

ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.

SOURCE ShangPharma Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED